Table 3.
Summary of the genotoxicity & reproductive toxicology studies with bacterial cellulose.
Type of study | Cell line/animal model | Dosages | Main results | Ref. |
---|---|---|---|---|
In vitro | ||||
Comet assay | Chinese hamster ovary (CHO) cells | Assay: 0.1, 0.5 or 1 mg BC/ml | DNA damages in the presence of BC fibres are similar to the negative control for each BC concentration; | Moreira et al. [31] |
Positive control: hydrogen peroxide (100 mM) | Around 95% of cells showed none or insignificant DNA damage (comet class 0 and 1) | |||
Negative control: water | ||||
Ames test | Salmonella typhimurium (TA 89, TA 100, TA 1535, TA 1537, TA 1538) with and without metabolic activation | Assay: 0, 66.7, 100, 333, 667, 1000, and 2500 μg/plate | BC did not cause an increase in the number of histidine revertants (mutations) per plate in any bacterial strain, either in the presence or absence of S9 microsomal enzymes | Schmitt et al. [28] |
Positive controls used without metabolic activation:
|
||||
Salmonella tryphimurium (TA97a, TA98, TA100 and TA102) | Assay, with and without S9 mixture: 0.1, 0.5 or 1.0 mg BC/ml | The results obtained, in the presence of BC without S9 mixture, correspond to spontaneous reversion for each strain and are similar to those obtained to negative control; | Moreira et al. [31] | |
Negative control: distilled water | In the presence of S9 mixture, an increase of revertant colonies per plate, for the TA98 and TA100 strains, was detected as compared with control; however, the increases were in each case <2-fold and did not appear to be dose-related | |||
Positive controls:
|
||||
S. typhimurium (TA97, TA98, TA100, TA102) | Assay: 8, 40, 200, 1000 and 5000 μg CB/dish | The numbers of colonies of each group at any BC dose, with or without S9 did, did not exceed twice of those of spontaneous reverse mutation group; | Hagiwara et al. [30] | |
Positive controls without S9: 9-fluorenone, sodium azide, mitomycin C; | Reversion mutation colonies did not grow with increasing dosages of BC, when compared to the solvent plates, indicating that no dose-response relationship was reflected. | |||
Positive controls with S9: 1,8-dihydroxy anthraquinone, 2-amino fluorine | ||||
Cytogenetic Assay | CHO cells | Assay: 0.333 μg/ml to 10,000 μg/ml Cellulon in McCoy's Sa culture medium | No significant increase in cells with chromosomal aberrations was observed at the concentrations analysed; | [28] |
Positive controls: mitomycin C, nonactivation series; cyclophosphamide, metabolic activation series | BC was considered negative for inducing chromosomal aberrations in CHO cells under both non-activation and metabolic activation conditions | |||
UDSa Assay | Rat primary hepatocytes | Assay: replacement of the culture media with
|
BC did not to induce significant changes in the nuclear labelling of rat primary hepatocytes within the range of tested concentrations; | |
Positive controls: (2- acetylaminofluorene) | None of the criteria used to indicate UDS were approached by any of the analysed treatments and no dose-related response was observed | |||
Negative control:
|
||||
CHO/HGPRTb Forward Mutation Assay | CHO-KI-BH4 cells | Assay with and without S9 metabolic activation: BC at 0.098-5.0 mg/ml, in F12 culture medium | BC was considered negative for inducing forward mutations at the HGPRT locus in CHO cells under both nonactivation and S9 metabolic activation conditions | |
Negative control: Sucrose | ||||
Positive control: (nonactivation assay, 5-bromo-2′ deoxyuridine (BrdU) | ||||
Metabolic activation: 3-methylcholanthrene | ||||
LALc assay | Assay: BC (0.5% Cellulon fibre, 99.5% water) | BC was negative for the presence of gram-negative bacterial endotoxin (<0,25 EU/ml) | ||
Negative: sterile water and endotoxin | ||||
Mouse sperm abnormality test | Kunming male mice | Assay: BC meals with 1.3, 2.5, 5.0 g/Kg bw, through oral gavage; | No significant differences in the rate of sperm abnormality between each BC dosage group and the solvent control group (CMC); | Li-ming et al. [29] |
Negative control: 1% CMC | There was a significant difference between the positive control group (cyclophosphamide) and the solvent control group | |||
Positive control: cyclophosphamide, (40 mg/kg bw) | ||||
Teratogenicity test | Fertilized SD rats | Assay: during gestation (7–16 days), dosage groups received oral gavage of 1.0, 2.0, 4.0 g BC/kg; | No deaths and no gross anatomical abnormalities were observed to any pregnant rat in all groups; | |
Control group: 10.0 mL/kg bw of 1% CMC | No abnormalities in the anatomy of the rats in each dose group; | |||
No significant differences in the:
|
||||
In vivo | ||||
Mouse bone marrow micronucleus assay | Kunming mice | Assay: oral gavage of 1.3, 2.5, 5.0 g BC/Kg bw | No significant differences in the incidence of micronucleus in the bone marrow of female and male mice in each dose group, as compared to the solvent control group (CMC); | Hagiwara et al. [30] |
Negative control: 1% CMC | The micronucleus rate in the positive control group (cyclophosphamide) was significantly higher than that of the CMC group | |||
Positive control: cyclophosphamide, at 40 mg/kg bw |
Unscheduled DNA Synthesis.
Chinese hamster ovary cell/hypoxanthine-guanine phosphoribosyl-transferase.
Limulus amebocyte Iysate.